L-propionyl-carnitine Protection of Mitochondria in Ischemic Rat Hearts
Overview
Authors
Affiliations
The energy-linked processes (transmembrane potential and oxidative phosphorylation) resulted in impaired mitochondria isolated from ischemic perfused rat hearts. Addition of 1.5 mM L-propionyl-carnitine to the perfusate significantly reduced the ischemic damage and ameliorated mitochondrial Ca2+ homeostasis. In both normoxic and ischemic hearts perfused with L-propionyl-carnitine a consistent amount of propionyl-CoA-otherwise undetectable-was produced. L-propionyl-carnitine treatment also prevented the decrease of succinyl-CoA associated with the ischemic condition. These results and the decrease of myocardial acetyl-CoA induced by exogenous L-propionyl-carnitine points to the anaplerotic effect of this ester. The consequently improved flux in the tricarboxylic-acid cycle may account for the observed protection of mitochondrial functions afforded by L-propionyl-carnitine in the ischemic perfused hearts.
Upregulation of Krebs cycle and anaerobic glycolysis activity early after onset of liver ischemia.
Chan T, Cassim S, Raymond V, Gottschalk S, Merlen G, Zwingmann C PLoS One. 2018; 13(6):e0199177.
PMID: 29902244 PMC: 6002017. DOI: 10.1371/journal.pone.0199177.
Ananthakrishnan R, Kaneko M, Hwang Y, Quadri N, Gomez T, Li Q Am J Physiol Heart Circ Physiol. 2008; 296(2):H333-41.
PMID: 19060123 PMC: 2643894. DOI: 10.1152/ajpheart.01012.2008.
Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective.
Wolff A, Rotmensch H, Stanley W, Ferrari R Heart Fail Rev. 2002; 7(2):187-203.
PMID: 11988642 DOI: 10.1023/a:1015384710373.
Broderick T, Driedzic W, Paulson D Mol Cell Biochem. 2000; 206(1-2):151-7.
PMID: 10839205 DOI: 10.1023/a:1007022114594.
Cittanti C, Colamussi P, Giganti M, Orlandi C, Uccelli L, Manfrini S Eur J Nucl Med. 1997; 24(7):762-6.
PMID: 9211762 DOI: 10.1007/BF00879664.